Discovery of 2-(2-benzoxazoyl amino)-4-aryl-5-cyanopyrimidine as negative allosteric modulators (NAMs) of metabotropic glutamate receptor 5 (mGlu₅): from an artificial neural network virtual screen to an in vivo tool compound

ChemMedChem. 2012 Mar 5;7(3):406-14. doi: 10.1002/cmdc.201100510. Epub 2012 Jan 20.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Allosteric Regulation
  • Animals
  • Anxiety Disorders / drug therapy
  • Anxiety Disorders / metabolism*
  • Behavior, Animal / drug effects
  • Benzoxazoles / chemical synthesis*
  • Benzoxazoles / pharmacokinetics
  • Benzoxazoles / pharmacology
  • Brain / drug effects*
  • Brain / metabolism
  • Drug Discovery
  • Glutamic Acid / metabolism
  • HEK293 Cells
  • High-Throughput Screening Assays
  • Humans
  • Injections, Intraperitoneal
  • Mice
  • Mice, Inbred C57BL
  • Neural Networks, Computer
  • Psychotropic Drugs / chemical synthesis*
  • Psychotropic Drugs / pharmacokinetics
  • Psychotropic Drugs / pharmacology
  • Pyrimidines / chemical synthesis*
  • Pyrimidines / pharmacokinetics
  • Pyrimidines / pharmacology
  • ROC Curve
  • Receptor, Metabotropic Glutamate 5
  • Receptors, Metabotropic Glutamate / antagonists & inhibitors*
  • Receptors, Metabotropic Glutamate / metabolism
  • Small Molecule Libraries

Substances

  • Benzoxazoles
  • Psychotropic Drugs
  • Pyrimidines
  • Receptor, Metabotropic Glutamate 5
  • Receptors, Metabotropic Glutamate
  • Small Molecule Libraries
  • Glutamic Acid